P Schmid-Grendelmeier

Summary

Country: Switzerland

Publications

  1. ncbi request reprint Tropical dermatology. Part I
    Peter Schmid-Grendelmeier
    Department of Dermatology, University Hospital, Gloriastrasse 31, CH 8190 Zurich, Switzerland
    J Am Acad Dermatol 46:571-83. 2002
  2. ncbi request reprint Eosinophils express functional IL-13 in eosinophilic inflammatory diseases
    Peter Schmid-Grendelmeier
    Swiss Institute for Allergy and Asthma Research, Davos Platz, Switzerland
    J Immunol 169:1021-7. 2002
  3. ncbi request reprint [Pollen as the cause of allergies]
    P Schmid-Grendelmeier
    Schweiz Institut für Allergie und Asthmaforschung, SIAF Davos
    Ther Umsch 58:285-91. 2001
  4. ncbi request reprint Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema
    Barbra Fischer Casagrande
    Allergy Unit, Department of Dermatology, Zurich, Switzerland
    J Invest Dermatol 126:2414-21. 2006
  5. ncbi request reprint Teledermatology in sub-Saharan Africa
    Peter Schmid-Grendelmeier
    Universitatsspital Zurich, Dermatologische Klinik, Zurich, Switzerland
    Curr Probl Dermatol 32:233-46. 2003
  6. ncbi request reprint Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy
    A Roll
    Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland
    J Investig Allergol Clin Immunol 16:79-85. 2006
  7. ncbi request reprint Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatment
    G Senti
    Unit for Experimental Immunotherapy, Department of Dermatology, University of Zurich, Zurich, Switzerland
    Dermatology 213:228-33. 2006
  8. ncbi request reprint Coated textiles in the treatment of atopic dermatitis
    S Haug
    Allergy Unit, Department of Dermatology, University Hospital of Zurich, Switzerland
    Curr Probl Dermatol 33:144-51. 2006
  9. ncbi request reprint In vitro and in vivo allergenicity of recombinant Bet v 1 compared to the reactivity of natural birch pollen extract
    S Tresch
    Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Clin Exp Allergy 33:1153-8. 2003
  10. ncbi request reprint The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated ("extrinsic") and the nonallergic ("intrinsic") AEDS
    B Wuthrich
    Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland
    J Investig Allergol Clin Immunol 13:1-5. 2003

Collaborators

Detail Information

Publications30

  1. ncbi request reprint Tropical dermatology. Part I
    Peter Schmid-Grendelmeier
    Department of Dermatology, University Hospital, Gloriastrasse 31, CH 8190 Zurich, Switzerland
    J Am Acad Dermatol 46:571-83. 2002
  2. ncbi request reprint Eosinophils express functional IL-13 in eosinophilic inflammatory diseases
    Peter Schmid-Grendelmeier
    Swiss Institute for Allergy and Asthma Research, Davos Platz, Switzerland
    J Immunol 169:1021-7. 2002
    ..In conclusion, human eosinophils are able to produce and release functional IL-13 in eosinophilic inflammatory responses...
  3. ncbi request reprint [Pollen as the cause of allergies]
    P Schmid-Grendelmeier
    Schweiz Institut für Allergie und Asthmaforschung, SIAF Davos
    Ther Umsch 58:285-91. 2001
    ..Finally, occupational and travelling aspects of pollinosis are briefly discussed...
  4. ncbi request reprint Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema
    Barbra Fischer Casagrande
    Allergy Unit, Department of Dermatology, Zurich, Switzerland
    J Invest Dermatol 126:2414-21. 2006
    ..Recombinant yeast allergens represent a useful tool to study molecular structures and differential sensitization patterns in the pathogenesis of AE...
  5. ncbi request reprint Teledermatology in sub-Saharan Africa
    Peter Schmid-Grendelmeier
    Universitatsspital Zurich, Dermatologische Klinik, Zurich, Switzerland
    Curr Probl Dermatol 32:233-46. 2003
  6. ncbi request reprint Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy
    A Roll
    Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland
    J Investig Allergol Clin Immunol 16:79-85. 2006
    ..L. Mueller classification, concentration of venom inducing positive skin tests, level of specific IgE, serum tryptase concentration, and hymenoptera venom used for treatment...
  7. ncbi request reprint Antimicrobial silk clothing in the treatment of atopic dermatitis proves comparable to topical corticosteroid treatment
    G Senti
    Unit for Experimental Immunotherapy, Department of Dermatology, University of Zurich, Zurich, Switzerland
    Dermatology 213:228-33. 2006
    ..Atopic dermatitis (AD) is aggravated by mechanical irritation and bacterial colonization...
  8. ncbi request reprint Coated textiles in the treatment of atopic dermatitis
    S Haug
    Allergy Unit, Department of Dermatology, University Hospital of Zurich, Switzerland
    Curr Probl Dermatol 33:144-51. 2006
    ..Silk can be coated with antimicrobials (Dermasilk). The combination of the smoothness of silk with an antimicrobial finish appears to make an ideal textile for patients suffering from AD...
  9. ncbi request reprint In vitro and in vivo allergenicity of recombinant Bet v 1 compared to the reactivity of natural birch pollen extract
    S Tresch
    Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Clin Exp Allergy 33:1153-8. 2003
    ..Diagnostic procedures using natural extracts show only limited quantitative correlation between in vivo and in vitro results. Highly pure recombinant allergens might show more predictive findings...
  10. ncbi request reprint The atopic eczema/dermatitis syndrome. Epidemiology, natural course, and immunology of the IgE-associated ("extrinsic") and the nonallergic ("intrinsic") AEDS
    B Wuthrich
    Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland
    J Investig Allergol Clin Immunol 13:1-5. 2003
    ..The risk of an "atopy march" is significantly lower in children with the non-IgE-associated type...
  11. doi request reprint [Recombinant allergens. For routine use or still only science?]
    P Schmid-Grendelmeier
    Dermatologische Klinik, Universitatsspital, Gloriastr 31, 8091, Zurich, Schweiz
    Hautarzt 61:946-53. 2010
    ....
  12. doi request reprint [Pollen allergy and immunotherapy]
    P Schmid-Grendelmeier
    Allergiestation, Dermatologische Klinik, Universitatsspital Zurich
    Ther Umsch 69:239-48. 2012
    ..Several approaches studying changed application regimens and using molecular technologies to improve the efficacy of SIT are undergoing and will possibly substantially improve the efficacy, safety and acceptance of SIT...
  13. ncbi request reprint The Pictorial Representation of Illness and Self Measure (PRISM) instrument reveals a high burden of suffering in patients with chronic urticaria
    B Töndury
    Allergy Unit, Department of Dermatology, University Hospital of Zurich, Switzerland
    J Investig Allergol Clin Immunol 21:93-100. 2011
    ..Chronic urticaria severely affects quality of life. To date, no gold standard has been established to measure the burden of suffering, which often correlates poorly with the skin symptoms observed in patients with chronic urticaria...
  14. ncbi request reprint Altered intracellular expression of the chemokines MIP-1alpha, MIP-1beta and IL-8 by peripheral blood CD4+ and CD8+ T cells in mild allergic asthma
    M Grob
    Clinical Immunology, Department of Internal Medicine, University Hospital, Zurich, Switzerland
    Allergy 58:239-45. 2003
    ..We now report use of whole blood culture and flow cytometry to assess the influence of mild allergic asthma on peripheral T-cell chemokine expression...
  15. ncbi request reprint Natural course of AEDS
    B Wuthrich
    Allergy Unit, Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, CH 8091Zurich, Switzerland
    Allergy 57:267-8. 2002
  16. ncbi request reprint Ultrarush immunotherapy in a patient with occupational allergy to bumblebee venom (Bombus terrestris)
    A Roll
    Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland
    J Investig Allergol Clin Immunol 15:305-7. 2005
    ..Two months after reaching the maintenance dose of 80 microg, the efficacy of the treatment was demonstrated by sting challenge...
  17. ncbi request reprint The role of sensitization to Malassezia sympodialis in atopic eczema
    Peter Schmid-Grendelmeier
    Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland
    Chem Immunol Allergy 91:98-109. 2006
    ....
  18. ncbi request reprint Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort
    Dagmar Simon
    Department of Dermatology, University Hospital Bern, Bern, Switzerland
    Dermatology 213:313-8. 2006
    ..Controlled studies established the efficacy and good tolerability of pimecrolimus cream 1% for the treatment of atopic dermatitis but they may not reflect real-life use...
  19. ncbi request reprint Atopic eczema: genetics or environment?
    Brunello Wuthrich
    Spital Zollikerberg, Allergologie, klinische Immunologie und Dermatologie, Trichtenhauserstrasse 20, 8125 Zollikerberg, Switzerland
    Ann Agric Environ Med 14:195-201. 2007
    ..From the therapeutic point of view, besides emollients and local corticosteroids, topic immunomodulatory drugs (tacrolimus and pimecrolimus) have substantially improved the treatment of AE...
  20. ncbi request reprint T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma
    Axel Trautmann
    Swiss Institute of Allergy and Asthma Research SIAF, Davos, Switzerland
    J Allergy Clin Immunol 109:329-37. 2002
    ..Asthma is an inflammatory airway disease associated with an infiltration of T cells and eosinophils, increased levels of pro-inflammatory cytokines, and shedding of bronchial epithelial cells (ECs)...
  21. ncbi request reprint Atopic dermatitis
    Mark Boguniewicz
    Division of Pediatric Allergy Immunology, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA
    J Allergy Clin Immunol 118:40-3. 2006
  22. ncbi request reprint Tropical dermatology. Part II
    Oliverio Welsh
    Department of Dermatology, Universidad Autonoma de Nuevo Leon, School of Medicine, Monterrey, Mexico
    J Am Acad Dermatol 46:748-63. 2002
  23. ncbi request reprint High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome
    Aurore de Lavareille
    Department of Immunology, Hopital Erasme, ULB, Brussels, Belgium
    J Allergy Clin Immunol 110:476-9. 2002
    ..In contrast, serum thymus and activation-regulated chemokine levels are consistently increased in such patients compared with others with persistent idiopathic hyper-eosinophilia and could therefore represent a useful diagnostic tool...
  24. ncbi request reprint Significantly elevated systemic levels after occlusive application of topical tacrolimus in atopic dermatitis
    Mirjam Beyerler
    Dermatology 212:260-1. 2006
  25. ncbi request reprint Wheat and maize thioredoxins: a novel cross-reactive cereal allergen family related to baker's asthma
    Michael Weichel
    Swiss Institute of Allergy and Asthma Research, Davos, Switzerland
    J Allergy Clin Immunol 117:676-81. 2006
    ..Although several wheat allergens related to baker's asthma have been described, standardized reagents for a reliable diagnosis are not yet available...
  26. ncbi request reprint Absence of T-regulatory cell expression and function in atopic dermatitis skin
    Johan Verhagen
    Swiss Institute of Allergy and Asthma Research, Davos Platz, Switzerland
    J Allergy Clin Immunol 117:176-83. 2006
    ..Increasing the number and activity of regulatory T cells in affected organs has been suggested as a remedy in various inflammatory diseases, including allergy...
  27. ncbi request reprint IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis
    Peter Schmid-Grendelmeier
    Swiss Institute of Allergy and Asthma Research, Davos, Switherland
    J Allergy Clin Immunol 115:1068-75. 2005
    ..Autoreactivity of patients with atopic dermatitis (AD) to human proteins has been postulated as a decisive pathogenetic factor for AD...
  28. ncbi request reprint Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective
    Leslie R Bisset
    Swiss National Center for Retroviruses, University of Zurich, Zurich, Switzerland
    Curr Opin Pulm Med 11:35-42. 2005
    ..Based on a series of selected references published during the last year, this review now summarizes recent advances and discusses the likely implications of these findings...
  29. ncbi request reprint Microbial colonization and atopic dermatitis
    Antonie Roll
    Allergy Unit, Department of Dermatology, University Hospital, Zurich, Switzerland
    Curr Opin Allergy Clin Immunol 4:373-8. 2004
    ..Here we review relevant studies, published since June 2002, about immunological triggers in atopic dermatitis, with emphasis on the role of microbial colonization...
  30. ncbi request reprint A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in
    Sven Klunker
    Swiss Institute of Allergy and Asthma Research, Davos, Switzerland
    J Immunol 171:1078-84. 2003
    ..Keratinocytes undergoing apoptosis in acute eczematous lesions release chemokines that attract more T cells toward the epidermis, which may further augment the inflammation and keratinocyte apoptosis...